International Business Machines Corporation (using the trademark IBM), nicknamed Big Blue, is an American multinational technology company headquartered in Armonk, New York, and present in over 175 countries. It is a publicly traded company and one of the 30 companies in the Dow Jones Industrial Average. IBM is the largest industrial research organization in the world, with 19 research facilities across a dozen countries; for 29 consecutive years, from 1993 to 2021, it held the record for most annual U.S. patents generated by a business.
trading_symbol | registrant_name | time | price | change | percentage_change |
---|---|---|---|---|---|
IBM | INTERNATIONAL BUSINESS MACHINES CORP | 2025-10-16 22:22:40 | 275.96 | -0.01 | 0 |
trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBM | 0000051143 | INTERNATIONAL BUSINESS MACHINES CORP | US4592001014 | VGRQXHF3J8VDLUA7XE92 | 130871985 | NYSE | 3570 | Computer & office Equipment | 1231 | NY | 1 NEW ORCHARD ROAD | ARMONK | NY | 10504 | UNITED STATES | US | 9144991900 | 1 NEW ORCHARD RD, ARMONK, NY, 10504 | 1 NEW ORCHARD ROAD, ARMONK, NY, 10504 | — | Information technology | 1911-06-16 | Arvind Krishna | 270,300 | https://www.ibm.com/ | 159,200,000,000 | 2,284,546,988 | 931,519,242 | International Business Machines Corporation (using the trademark IBM), nicknamed Big Blue, is an American multinational technology company headquartered in Armonk, New York, and present in over 175 countries. It is a publicly traded company and one of the 30 companies in the Dow Jones Industrial Average. IBM is the largest industrial research organization in the world, with 19 research facilities across a dozen countries; for 29 consecutive years, from 1993 to 2021, it held the record for most annual U.S. patents generated by a business. | 2025-10-10 19:01:17 |
Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
---|---|---|---|---|---|---|
2024 | 159,200,000,000 | 37,300,000,000 | 30.5989 | 927,264,332 | 10,519,484 | 1.1475 |
2023 | 121,900,000,000 | -5,600,000,000 | -4.3922 | 916,744,848 | 9,639,237 | 1.0626 |
2022 | 127,500,000,000 | -3,900,000,000 | -2.968 | 907,105,611 | 7,795,625 | 0.8668 |
Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
---|---|---|---|---|---|---|---|---|
K.M. Keverian | Senior Vp | 2014 | 450,000 | 500,000 | 7,088,414 | 510,300 | 1,011,731 | 0 |
S.A. Mills | Executive Vp | 2014 | 730,500 | 0 | 4,886,428 | 703,500 | 94,941 | 0 |
V.M. Rometty | CEO, Chairman, President | 2014 | 1,500,000 | 0 | 12,460,409 | 3,600,000 | 381,991 | 0 |
M.J. Schroeter | CFO, Senior Vp | 2014 | 660,000 | 0 | 3,616,006 | 747,600 | 80,812 | 0 |
J.E. Kelly | Senior Vp | 2014 | 638,000 | 0 | 3,909,248 | 791,100 | 96,193 | 0 |
Fiscal Year | 2024 | 2023 | 2022 |
---|---|---|---|
Revenue | 62,753,000,000 | 61,860,000,000 | 60,530,000,000 |
Cost Of Revenue | 27,201,000,000 | 27,560,000,000 | 27,842,000,000 |
Gross Profit | 35,551,000,000 | 34,300,000,000 | 32,687,000,000 |
Research And Development Expenses | 7,479,000,000 | 6,775,000,000 | 6,567,000,000 |
General And Administrative Expenses | 19,688,000,000 | 19,003,000,000 | 18,609,000,000 |
Operating Expenses | — | — | — |
Operating Income | — | — | — |
Net Income | 6,023,000,000 | 7,502,000,000 | 1,639,000,000 |
Earnings Per Share Basic | 6.53 | 8.23 | 1.82 |
Earnings Per Share Diluted | 6.43 | 8.14 | 1.8 |
Weighted Average Shares Outstanding Basic | 921,767,834 | 911,210,319 | 902,664,190 |
Weighted Average Shares Outstanding Diluted | 937,161,224 | 922,073,828 | 912,269,062 |
Fiscal Year | 2024 | 2023 | 2022 |
---|---|---|---|
Cash And Cash Equivalents | 13,947,000,000 | 13,068,000,000 | 7,886,000,000 |
Marketable Securities Current | — | — | — |
Accounts Receivable | 6,804,000,000 | 7,214,000,000 | 6,541,000,000 |
Inventories | 1,289,000,000 | 1,161,000,000 | 1,552,000,000 |
Non Trade Receivables | — | — | 6,851,000,000 |
Other Assets Current | — | — | — |
Total Assets Current | 34,482,000,000 | 32,908,000,000 | 29,118,000,000 |
Marketable Securities Non Current | — | — | — |
Property Plant And Equipment | — | — | 5,334,000,000 |
Other Assets Non Current | — | — | — |
Total Assets Non Current | 102,693,000,000 | 102,333,000,000 | 98,125,000,000 |
Total Assets | 137,175,000,000 | 135,241,000,000 | 127,243,000,000 |
Accounts Payable | 4,032,000,000 | 4,132,000,000 | 4,051,000,000 |
Deferred Revenue | 13,907,000,000 | 13,451,000,000 | 12,032,000,000 |
Short Term Debt | 5,089,000,000 | 6,426,000,000 | 4,760,000,000 |
Other Liabilities Current | — | — | — |
Total Liabilities Current | 33,142,000,000 | 34,122,000,000 | 31,505,000,000 |
Long Term Debt | 49,884,000,000 | 50,121,000,000 | 46,189,000,000 |
Other Liabilities Non Current | 11,048,000,000 | 11,475,000,000 | 12,243,000,000 |
Total Liabilities Non Current | 76,641,000,000 | 78,506,000,000 | 73,717,000,000 |
Total Liabilities | 109,783,000,000 | 112,628,000,000 | 105,222,000,000 |
Common Stock | 61,380,000,000 | 59,643,000,000 | 58,343,000,000 |
Retained Earnings | 151,163,000,000 | 151,276,000,000 | 149,825,000,000 |
Accumulated Other Comprehensive Income | -15,269,000,000 | -18,761,000,000 | -16,740,000,000 |
Total Shareholders Equity | 27,307,000,000 | 22,533,000,000 | 21,944,000,000 |
Fiscal Year | 2024 | 2023 | 2022 |
---|---|---|---|
Depreciation And Amortization | 2,168,000,000 | 2,109,000,000 | 2,407,000,000 |
Share Based Compensation Expense | 1,311,000,000 | 1,133,000,000 | 987,000,000 |
Other Non Cash Income Expense | — | 17,000,000 | -225,000,000 |
Change In Accounts Receivable | 374,000,000 | -725,000,000 | 539,000,000 |
Change In Inventories | 166,000,000 | -390,000,000 | -71,000,000 |
Change In Non Trade Receivables | — | — | — |
Change In Other Assets | — | — | — |
Change In Accounts Payable | -13,000,000 | 65,000,000 | 213,000,000 |
Change In Other Liabilities | -1,601,000,000 | -1,466,000,000 | 115,000,000 |
Cash From Operating Activities | 13,445,000,000 | 13,931,000,000 | 10,435,000,000 |
Purchases Of Marketable Securities | 7,762,000,000 | 11,143,000,000 | 5,930,000,000 |
Sales Of Marketable Securities | 6,544,000,000 | 10,647,000,000 | 4,665,000,000 |
Acquisition Of Property Plant And Equipment | 1,048,000,000 | 1,245,000,000 | 1,346,000,000 |
Acquisition Of Business | 3,289,000,000 | 5,082,000,000 | 2,348,000,000 |
Other Investing Activities | — | — | — |
Cash From Investing Activities | -4,937,000,000 | -7,070,000,000 | -4,202,000,000 |
Tax Withholding For Share Based Compensation | 651,000,000 | 402,000,000 | 407,000,000 |
Payments Of Dividends | 6,147,000,000 | 6,040,000,000 | 5,948,000,000 |
Issuance Of Common Stock | — | — | — |
Repurchase Of Common Stock | — | — | — |
Issuance Of Long Term Debt | — | — | — |
Repayment Of Long Term Debt | 6,615,000,000 | 5,082,000,000 | 6,800,000,000 |
Other Financing Activities | -145,000,000 | 176,000,000 | 176,000,000 |
Cash From Financing Activities | -7,079,000,000 | -1,769,000,000 | -4,958,000,000 |
Change In Cash | 1,071,000,000 | 5,101,000,000 | 1,032,000,000 |
Cash At End Of Period | 13,947,000,000 | 13,068,000,000 | 7,886,000,000 |
Income Taxes Paid | 1,723,000,000 | 1,564,000,000 | 1,865,000,000 |
Interest Paid | 1,978,000,000 | 1,668,000,000 | 1,401,000,000 |
Fiscal Year | 2024 | 2023 | 2022 |
---|---|---|---|
Earnings Per Share | 6.53 | 8.23 | 1.82 |
Price To Earnings Ratio | 33.6646 | 19.8724 | 77.4121 |
Earnings Growth Rate | -20.6561 | 352.1978 | -71.6069 |
Price Earnings To Growth Ratio | -1.6298 | 0.0564 | -1.0811 |
Book Value Per Share | 29.7168 | 24.8164 | 24.3956 |
Price To Book Ratio | 7.3975 | 6.5904 | 5.7752 |
Ebitda | 11,626,000,000 | 12,782,000,000 | 7,127,000,000 |
Enterprise Value | 243,658,222,948.22 | 192,507,447,672.45 | 170,239,357,729.1 |
Dividend Yield | 0.0303 | 0.0405 | 0.0468 |
Dividend Payout Ratio | 1.0206 | 0.8051 | 3.629 |
Debt To Equity Ratio | 2.0131 | 2.5095 | 2.3218 |
Capital Expenditures | — | — | 2,047,000,000 |
Free Cash Flow | — | — | 8,388,000,000 |
Return On Equity | 0.2206 | 0.3329 | 0.0747 |
One Year Beta | 0.7986 | 0.5232 | 0.5513 |
Three Year Beta | 0.5866 | 0.5371 | 0.8261 |
Five Year Beta | 0.8002 | 0.8192 | 0.8592 |
Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
---|---|---|---|---|---|
Brown Marianne Catherine | Director | 2025-09-30 | 324 | A | 2,947 |
Buberl Thomas | Director | 2025-09-30 | 324 | A | 13,428 |
FARR DAVID N | Director | 2025-09-30 | 209 | A | 22,273 |
Gorsky Alex | Director | 2025-09-30 | 381 | A | 32,805 |
HOWARD MICHELLE J | Director | 2025-09-30 | 292 | A | 15,580 |
Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
---|---|---|---|---|---|---|
Thomas H Tuberville | Senator | 2024-02-14 | Sale (Full) | 2024-01-19 | Joint | $1,001 - $15,000 |
Shelley M Capito | Senator | 2022-07-15 | Sale (Partial) | 2022-06-17 | Spouse | $1,001 - $15,000 |
Thomas H Tuberville | Senator | 2022-02-14 | Purchase | 2022-01-12 | Joint | $1,001 - $15,000 |
Gary C Peters | Senator | 2022-01-08 | Purchase | 2022-01-03 | Self | $1,001 - $15,000 |
Shelley M Capito | Senator | 2021-08-11 | Sale (Partial) | 2021-07-26 | Spouse | $1,001 - $15,000 |
Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
---|---|---|---|---|---|---|
Jonathan Jackson | 2025-09-23 | IL01 | Sale | 2025-08-13 | Spouse | $1,001 - $15,000 |
Julie Johnson | 2025-09-11 | TX32 | Sale (Partial) | 2025-08-14 | Joint | $1,001 - $15,000 |
Josh Gottheimer | 2025-09-05 | NJ05 | Sale (Partial) | 2025-08-12 | Joint | $1,001 - $15,000 |
Lisa McClain | 2025-08-13 | MI09 | Purchase | 2025-06-17 | Spouse | $1,001 - $15,000 |
Lisa McClain | 2025-08-13 | MI09 | Sale | 2025-07-16 | Spouse | $1,001 - $15,000 |
Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
---|---|---|---|---|
Bill Few Associates, Inc. | 2025-09-30 | 4,947,114 | 17,533 | 282.1602 |
LOCKERMAN FINANCIAL GROUP, INC. | 2025-09-30 | 216,982 | 769 | 282.1612 |
Carnegie Investment Counsel | 2025-09-30 | 9,847,861 | 34,902 | 282.1575 |
180 WEALTH ADVISORS, LLC | 2025-09-30 | 4,190,627 | 14,852 | 282.1591 |
Castle Rock Wealth Management, LLC | 2025-09-30 | 4,295,468 | 15,040 | 285.6029 |
Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
---|---|---|---|---|---|---|
CAPITAL MANAGEMENT INVESTMENT TRUST | 2025-08-31 | Institutional Shares | WSACX | 7,000 | 1,704,430 | 2.72 |
Northern Lights Fund Trust IV | 2025-07-31 | Main Thematic Innovation ETF | TMAT | 2,232 | 565,030.8 | 0.308 |
CALAMOS INVESTMENT TRUST/IL | 2025-07-31 | Class R6 | CVSOX | 119,870 | 30,345,090.5 | 0.185 |
CALAMOS INVESTMENT TRUST/IL | 2025-07-31 | Class I | CMNIX | 119,870 | 30,345,090.5 | 0.185 |
CALAMOS INVESTMENT TRUST/IL | 2025-07-31 | Class C | CVSCX | 119,870 | 30,345,090.5 | 0.185 |